Literature DB >> 24676628

Quality of care of rural rheumatoid arthritis patients in Austria.

Rudolf Puchner1, Hans Peter Brezinschek, Manfred Herold, Thomas Nothnagl, Andrea Studnicka-Benke, Josef Fritz, Burkhard F Leeb.   

Abstract

OBJECTIVES: To determine how fast rheumatoid arthritis (RA) was diagnosed in a group of patients in a rural area and whether medical care and patient satisfaction were adequate in a predominantly non-urban settlement.
METHODS: When visiting their rheumatologist, patients with RA were asked to complete a questionnaire at home after the consultation and then return it to an independent opinion research centre, where the data were collected and analysed. The form comprised various areas, namely demography, aspects of the diagnosis, medical care, therapeutic measures and the illness in a personal context.
RESULTS: Of 150 patients, 127 answered the questionnaire. A total of 63 % of the patients lived in settlements of less than 5,000 inhabitants, and a further 18 % in settlements of more than 5,000-50,000 inhabitants. The rheumatologist attended could be reached within 1 h for 90 % of the patients. In slightly fewer than 30 % of the respondents, the diagnosis of RA was made within 3 months, and in 44%, within 6 months. In 75 %, the diagnosis was made by a rheumatologist. After experiencing the first symptoms, 80 % of the respondents contacted their general practitioner. A high degree of satisfaction appears to originate from the information supplied by the rheumatologist attended. Most patients believed they were involved in decision making regarding their therapy.
CONCLUSION: The majority of the respondents came from rural areas. RA was diagnosed within 6 months for almost half of the patients questioned. Most patients believed they were well informed and involved in therapeutic decision making.

Entities:  

Mesh:

Year:  2014        PMID: 24676628     DOI: 10.1007/s00508-014-0540-6

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  26 in total

Review 1.  Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys.

Authors:  S M M Verstappen; J W J Bijlsma; H Verkleij; E Buskens; A A M Blaauw; E J ter Borg; J W G Jacobs
Journal:  Arthritis Rheum       Date:  2004-06-15

2.  Delay in receiving rheumatology care leads to long-term harm.

Authors:  Vivian Bykerk; Paul Emery
Journal:  Arthritis Rheum       Date:  2010-12

3.  [Job satisfaction and future prospects among Austrian rheumatologists].

Authors:  R Puchner
Journal:  Z Rheumatol       Date:  2010-11       Impact factor: 1.372

4.  Long-term impact of delay in assessment of patients with early arthritis.

Authors:  Michael P M van der Linden; Saskia le Cessie; Karim Raza; Diane van der Woude; Rachel Knevel; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  Arthritis Rheum       Date:  2010-12

5.  Rheumatology outcomes: the patient's perspective.

Authors:  Alison Carr; Sarah Hewlett; Rod Hughes; Helene Mitchell; Sarah Ryan; Maggie Carr; John Kirwan
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

6.  Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Authors:  Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; C F Allaart; D van Zeben; P J S M Kerstens; J M W Hazes; A H Zwinderman; H K Ronday; K H Han; M L Westedt; A H Gerards; J H L M van Groenendael; W F Lems; M V van Krugten; F C Breedveld; B A C Dijkmans
Journal:  Arthritis Rheum       Date:  2005-11

7.  Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

Authors:  Timo Möttönen; Pekka Hannonen; Markku Korpela; Martti Nissilä; Hannu Kautiainen; Jorma Ilonen; Leena Laasonen; Oili Kaipiainen-Seppänen; Per Franzen; Tapani Helve; Juhani Koski; Marianne Gripenberg-Gahmberg; Riitta Myllykangas-Luosujärvi; Marjatta Leirisalo-Repo
Journal:  Arthritis Rheum       Date:  2002-04

Review 8.  [Treat-to-target from the perspective of office-based rheumatology].

Authors:  K Krüger; K Karberg
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

Review 9.  [Treat-to-target from the patient perspective].

Authors:  E Gromnica-Ihle; M Rink
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

10.  Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis.

Authors:  Victoria Bejarano; Mark Quinn; Philip G Conaghan; Richard Reece; Anne-Maree Keenan; David Walker; Andrew Gough; Michael Green; Dennis McGonagle; Ade Adebajo; Stephen Jarrett; Sheelagh Doherty; Lesley Hordon; Richard Melsom; Kristina Unnebrink; Hartmut Kupper; Paul Emery
Journal:  Arthritis Rheum       Date:  2008-10-15
View more
  4 in total

1.  [Primary Health Care in Austria - Tu Felix Austria nube - Concept for networking in the primary care of Upper Austria].

Authors:  Johannes Kriegel; Erwin Rebhandl; Wolfgang Hockl; Anna-Maria Stöbich
Journal:  Wien Med Wochenschr       Date:  2016-11-22

2.  Rheumatological care in rural areas : The Rheuma-Bus project 2018.

Authors:  Rudolf Puchner; Gertraud Schaffer; Judith Sautner; Alois Alkin; Klaus Machold; Tanja Stamm
Journal:  Wien Klin Wochenschr       Date:  2020-03-18       Impact factor: 1.704

3.  Improving patient flow of people with rheumatoid arthritis has the potential to simultaneously improve health outcomes and reduce direct costs.

Authors:  R Puchner; R Hochreiter; H Pieringer; A Vavrovsky
Journal:  BMC Musculoskelet Disord       Date:  2017-01-07       Impact factor: 2.362

4.  Global Rural and Remote Patients With Rheumatoid Arthritis: A Systematic Review.

Authors:  Emilie Pianarosa; Kelsey Chomistek; Ralph Hsiao; Salman Anwar; Valerie Umaefulam; Glen Hazlewood; Cheryl Barnabe
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-02-22       Impact factor: 5.178

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.